Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial

By sjmartinez • August 1, 2024

Cooper SE, Zhang S, Haines D, Mayer KH, Amico KR, Landovitz RJ, Hendrix CW, Marzinke MA, Chege W, McCauley M, Gulick RM. Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial. AIDS Behav. 2024 Jul 31. doi: 10.1007/s10461-024-04451-7. Epub ahead of print. PMID: 39083151.

Tags: Adherence, CASI, HIV prevention, Infectious Diseases, Maraviroc, PrEP, Publications, Tenofovir

Non-viable Aspergillus fumigatus promotes chronic inflammation and angiogenesis in a murine fungus ball model

Hamashima R, Tashiro M, Nakano Y, Shirahige T, Namie H, Yano H, Ito Y, Yoshida M, Hirayama T, Takeda K, Iwanaga N, Kakiuchi S, Nishi[...]

Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin

Dong S, Harris C, Ly A, Lee PS. Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin. Cureus. 2026 Feb 17;18(2):e103789. doi: 10.7759/cureus.103789. PMID: 41869147; PMCID:[...]

“It’s being uncomfortable for who you are, because I think HIV is part of me … “: psychosocial adaptation and treatment engagement among GBMSM older and younger than 30 years engaged in a coping and disclosure skills intervention in the Eastern Cape, South Africa

de Vos L, Rutt K, Metula A, Peters RPH, Bongo C, Daniels J. "It's being uncomfortable for who you are, because I think HIV is[...]